Key result
Atracurium at a dose of 1 mg/kg provided a significantly higher rate of excellent intubating conditions (51.4%) compared to 0.6 mg/kg (26.3%) for rapid sequence induction of anesthesia.
Why the study?
Succinylcholine and high-dose rocuronium are commonly used for rapid sequence induction of anesthesia, but their usage is limited or contraindicated in certain circumstances.
Does high-dose atracurium without priming improve intubating conditions in surgical patients undergoing rapid sequence induction of anesthesia?
RCT (n=115)
Double-blind
Block randomization
No
Does high-dose atracurium without priming improve intubating conditions in surgical patients undergoing rapid sequence induction of anesthesia?
Absolute Event Rate: 51.4% vs 26.3%
p-value: p=0.03
A relatively high dose of atracurium (1 mg/kg or 0.75 mg/kg) without priming provides better intubating conditions compared to 0.6 mg/kg for rapid sequence induction of anesthesia.
Higher atracurium doses improve RSI intubating conditions; extends dose-response evidence for non-depolarizing blockade without priming.
Background and Aims: Succinylcholine and high dose rocuronium are neuromuscular blocking agents commonly used for rapid sequence induction of anesthesia. Their usage is limited or contraindicated in some circumstances. The aim of this study is to determine the dosage and efficacy of atracurium without priming for rapid sequence induction of anesthesia. Material and Methods: One hundred fifteen surgical patients under general anesthesia were randomised into three groups. All patients were given 2-3 mg/kg propofol and 1 μg/kg fentanyl intravenously for the induction of anesthesia followed by different doses of atracurium (0.6 mg/kg, 0.75 mg/kg or 1 mg/kg) without a priming dose. Tracheal intubation was performed within one minute after the administration of the study drugs. The intubating conditions, vocal cord movement and diaphragm movement were graded as the primary endpoints. Statistical analysis was done using one-way analysis of variance (ANOVA) and Post Hoc tests. Results: Atracurium doses of 1 mg/kg, 0.75 mg/kg, and 0.6 mg/kg provided 51.4%, 43.6% and 26.3% success rates of intubation without coughing or bucking, respectively (P = 0.03). The intubating conditions were graded as excellent or good in 86.5% of the 1 mg/kg atracurium group patients and in 84.6% of the 0.75 mg/kg group patients (P < 0.05). An atracurium dose of 1 mg/kg facilitated significant differences in vocal cord and diaphragm paralysis compared with the dose of 0.6 mg/kg (P = 0.03). Conclusion: The administration of a relatively high dose of atracurium without priming can be used as an alternative neuromuscular blocking agent for rapid sequence induction of anesthesia in some circumstances.
No takes yet. Share an insight, caveat, or question.
Chalermkitpanit et al. (2020) conducted an RCT in Surgical patients requiring general anesthesia (n=115). Atracurium vs. 0.6 mg/kg atracurium was evaluated on Excellent intubating conditions (easy passage of tube without coughing/bucking) at one minute (p=0.03). Atracurium at a dose of 1 mg/kg provided a significantly higher rate of excellent intubating conditions (51.4%) compared to 0.6 mg/kg (26.3%) for rapid sequence induction of anesthesia.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: